UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Catalyst Pharmaceuticals is implementing good security practices.
Catalyst Pharmaceuticals is a biopharmaceutical company based in Coral Gables, Florida. The company is developing therapeutics for rare neurological diseases, including the phosphate salt of amifampridine for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) under the trade name "Firdapse", and CPP-115 (a GABA transaminase) for the treatment of infantile spasms.
This report shows a preliminary security rating for Catalyst Pharmaceuticals. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
The Personal Information Protection and Electronic Documents Act (PIPEDA) is the federal privacy ...
The Vendor Security Alliance (VSA) questionnaire was created by a coalition of companies committed ...
Compare Catalyst Pharmaceuticals's security performance with other companies